Aveo Agrees To $18M Deal To End Cancer Drug Investor Suit
Investors in Aveo Pharmaceuticals Inc. on Friday asked a Massachusetts federal judge for an initial sign-off on a deal worth more than $17.7 million that would resolve a class action alleging...To view the full article, register now.
Already a subscriber? Click here to view full article